Mediclinic International PLC (MDCM.L)
MDCM.L on London Stock Exchange
349.70GBp
1:16pm BST
349.70GBp
1:16pm BST
Change (% chg)
2.70 (+0.78%)
2.70 (+0.78%)
Prev Close
347.00
347.00
Open
344.70
344.70
Day's High
352.50
352.50
Day's Low
343.00
343.00
Volume
482,533
482,533
Avg. Vol
1,103,431
1,103,431
52-wk High
712.40
712.40
52-wk Low
293.10
293.10
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Sep | 1,387.00 | -0.228 |
| FY 2018 | Mar '18 | 1,465.00 | -0.600 |
| Sep | 1,405.00 | -0.068 | |
| FY 2017 | Mar '17 | 1,466.00 | 0.161 |
| Sep | 1,283.00 | 0.149 |
*Note: Units in Millions ofBritish Pounds
**Note: Units in British Pounds
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Mar-19 | 11 | 2,936.36 | 2,981.88 | 2,910.76 | 2,916.53 |
| Year Ending Mar-20 | 11 | 3,060.65 | 3,169.23 | 2,956.00 | 3,076.54 |
| Earnings (per share) | |||||
| Year Ending Mar-19 | 12 | 26.69 | 30.16 | 24.06 | 32.10 |
| Year Ending Mar-20 | 12 | 28.52 | 36.46 | 26.03 | 35.17 |
| LT Growth Rate (%) | 2 | 4.77 | 10.40 | -0.86 | 6.12 |
Sales and Profit Figures in British Pound (GBP);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 22.09 | 27.89 | 32.55 | |
| P/E High - Last 5 Yrs. | -- | 108.94 | 48.10 | |
| P/E Low - Last 5 Yrs. | -- | 20.04 | 23.42 | |
| Beta | 1.03 | 0.61 | 0.87 | |
| Price to Sales (TTM) | 1.84 | 18.19 | 8.39 | |
| Price to Book (MRQ) | 1.24 | 4.15 | 5.27 | |
| Price to Tangible Book (MRQ) | 2.62 | 4.61 | 6.74 | |
| Price to Cash Flow (TTM) | 13.03 | 16.77 | 24.12 | |
| % Owned Institutions | -- | 7.38 | 1.65 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.03 | 1.35 | |
| Dividend Yield - 5 Year Avg | -- | 0.80 | 1.37 | |
| Dividend 5 Year Growth Rate | -- | 10.04 | 4.70 | |
| Payout Ratio(TTM) | 25.43 | 13.58 | 39.61 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 33.64 | 12.07 | 13.46 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 30.47 | 10.44 | 8.04 | |
| Sales - 5 Yr. Growth Rate | -- | 15.32 | 10.84 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 29.83 | 59.31 | 47.73 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 4.44 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 10.35 | 10.46 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 24.73 | 14.68 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.66 | 9.31 | 2.18 |
| Current Ratio (MRQ) | 1.81 | 9.61 | 2.98 |
| LT Debt to Equity (MRQ) | 47.99 | 49.23 | 11.33 |
| Total Debt to Equity (MRQ) | 49.68 | 62.32 | 16.01 |
| Interest Coverage (TTM) | 6.42 | 32.74 | 28.44 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 38.30 | 39.96 | 52.41 | |
| Gross Margin - 5 Yr. Avg. | -- | 40.86 | 50.39 | |
| EBITD Margin (TTM) | 18.52 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -0.45 | 12.41 | |
| Operating Margin (TTM) | 13.17 | -4.12 | 5.73 | |
| Operating Margin - 5 Yr. Avg. | -- | -11.40 | 8.01 | |
| Pre-Tax Margin (TTM) | 11.17 | 5.41 | 4.75 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -0.64 | 8.28 | |
| Net Profit Margin (TTM) | 8.84 | 2.56 | 1.48 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -3.20 | 4.69 | |
| Effective Tax Rate (TTM) | 20.85 | 19.55 | 22.13 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 36.80 | 22.58 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 93,364 | 6,767,498 | 820,403,999 | |
| Net Income/Employee (TTM) | 8,253 | -990,204 | 92,865,213 | |
| Receivable Turnover (TTM) | -- | 7.98 | 5.82 | |
| Inventory Turnover (TTM) | -- | 66.47 | 3.41 | |
| Asset Turnover (TTM) | -- | 0.61 | 0.90 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 5.14 | 10.60 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.83 | 11.78 | |
| Return on Investment (TTM) | -- | 6.65 | 13.83 | |
| Return on Investment - 5 Yr. Avg. | -- | 7.41 | 15.32 | |
| Return on Equity (TTM) | -- | 10.54 | 15.25 | |
| Return on Equity - 5 Yr. Avg. | -- | 11.14 | 16.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 30.47 | -- | -- |
| EPS (TTM) % | 5.16 | -- | -- |
| Dividend % | 0.00 | -- | -- |
Note: Units in Millions of US Dollars
Performance for Mediclinic International PLC
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -8.41 | -10.29 | 51 | 33 |
| 13 Week | -6.16 | -8.59 | 99 | 36 |
| 26 Week | -1.93 | -4.73 | 99 | 21 |
| 52 Week | -22.83 | -28.81 | 78 | 15 |
| YTD | -11.02 | -16.52 | 96 | 12 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- London's shares off six-month highs, Bunzl suffers worst day in a decade
- UPDATE 2-London's shares off 6-month highs, Bunzl suffers worst day in a decade
- Mining shares lead London's FTSE 100 lower; Bunzl drops on weak Q1
- Mediclinic expects core profit to drop 3.5 pct for full year
- BRIEF-Mediclinic International Says 2019 Results Were In Line With Market Expectations
Institutional Holders
| % Shares Owned: | 37.90% |
| # of Holders: | 214 |
| Total Shares Held: | 279,450,106 |
| 3 Mo. Net Change: | -18,987,400 |
| # New Positions: | 2 |
| # Closed Positions: | 14 |
| # Increased Positions: | 17 |
| # Reduced Positions: | 30 |
| # Net Buyers: | -13 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.